Akhras K - Search Results

1

Outcomes and management costs in patients hospitalized for skin and skin-structure infections.

Itani KM, Merchant S, Lin SJ, Akhras K, Alandete JC, Hatoum HT. Itani KM, et al. Among authors: akhras k. Am J Infect Control. 2011 Feb;39(1):42-9. doi: 10.1016/j.ajic.2010.03.018. Epub 2010 Jul 29. Am J Infect Control. 2011. PMID: 20673598

2

Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.

Itani KM, Akhras KS, Stellhorn R, Quintana A, Budd D, Merchant S. Itani KM, et al. Pharmacoeconomics. 2009;27(5):421-30. doi: 10.2165/00019053-200927050-00006. Pharmacoeconomics. 2009. PMID: 19586079

3

The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study.

Hatoum HT, Akhras KS, Lin SJ. Hatoum HT, et al. Diagn Microbiol Infect Dis. 2009 Jul;64(3):305-10. doi: 10.1016/j.diagmicrobio.2009.02.005. Diagn Microbiol Infect Dis. 2009. PMID: 19501792

4

Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients.

Marwick C, Broomhall J, McCowan C, Phillips G, Gonzalez-McQuire S, Akhras K, Merchant S, Nathwani D, Davey P. Marwick C, et al. Among authors: akhras k. J Antimicrob Chemother. 2011 Feb;66(2):387-97. doi: 10.1093/jac/dkq362. Epub 2010 Oct 5. J Antimicrob Chemother. 2011. PMID: 20926396

5

Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation.

Kongnakorn T, Mwamburi M, Merchant S, Akhras K, Caro JJ, Nathwani D. Kongnakorn T, et al. Among authors: akhras k. Curr Med Res Opin. 2010 Jan;26(1):17-24. doi: 10.1185/03007990903358980. Curr Med Res Opin. 2010. PMID: 19895363

6

Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia.

McGarry LJ, Merchant S, Nathwani D, Pawar V, DeLong K, Thompson D, Akhras K, Ingham M, Weinstein MC. McGarry LJ, et al. Among authors: akhras k. J Med Econ. 2010 Mar;13(1):142-7. doi: 10.3111/13696991003604108. J Med Econ. 2010. PMID: 20136579 Free article.

7

Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.

Hatoum H, Khanna D, Lin SJ, Akhras KS, Shiozawa A, Khanna P. Hatoum H, et al. Postgrad Med. 2014 Mar;126(2):65-75. doi: 10.3810/pgm.2014.03.2741. Postgrad Med. 2014. PMID: 24685969

8

1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists.

Hatoum HT, Akhras K. Hatoum HT, et al. Among authors: akhras k. Ann Pharmacother. 1993 Sep;27(9):1106-19. doi: 10.1177/106002809302700917. Ann Pharmacother. 1993. PMID: 8219447

9

Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting.

Hatoum HT, Brazier JE, Akhras KS. Hatoum HT, et al. Value Health. 2004 Sep-Oct;7(5):602-9. doi: 10.1111/j.1524-4733.2004.75011.x. Value Health. 2004. PMID: 15367255 Free article.

10

Effects of severity of illness on resource use by survivors and nonsurvivors of severe sepsis at intensive care unit admission.

Teres D, Rapoport J, Lemeshow S, Kim S, Akhras K. Teres D, et al. Among authors: akhras k. Crit Care Med. 2002 Nov;30(11):2413-9. doi: 10.1097/00003246-200211000-00002. Crit Care Med. 2002. PMID: 12441747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters